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ABSTRACT
A reporter transcript containing the green fluorescent
protein (GFP) gene upstream of the destabilizing
30-untranslated region (30-UTR) of the murine IL-3
gene was inserted in mouse PB-3c-15 mast cells.
The GFP–IL-3 transcript was inherently unstable
due to the presence of an adenosine–uridine (AU)-
rich element (ARE) in the 30-UTR and was subject to
rapid decay giving a low baseline of GFP fluores-
cence. Transcript stabilization with ionomycin
resulted in an increase of fluorescence that is quanti-
tated by FACS analysis of responding cells. Using this
system we have identified okadaic acid as a novel
stabilizing compound, and investigated the upstream
signaling pathways leading to stabilization. This
reporter system has the advantage of speed and sim-
plicity over standard methods currently in use and in
addition to serving as a research tool it can be easily
automated to increase throughput for drug discovery.
INTRODUCTION
Regulating gene expression by modulating the turnover of
mRNA is an important post-transcriptional mechanism to
ensure a rapid cellular response to appropriate stimuli (1).
This is achieved by the generation of short-lived transcripts
with high turnover rates in the cytoplasm. The lability of these
transcripts is largely due to the presence of cis-elements pre-
sent in the transcript and a corresponding binding protein that
targets the transcript for rapid decay. Several such destabiliz-
ing elements, located both in the coding and non-coding
region, have been described: the CRD (coding region deter-
minant) of the c-myc and c-fos oncogenes, the CDE (consti-
tutive decay element) in the tumour necrosis factor a ðTNFa)
30-UTR and adenosine–uridine (AU)-rich elements (ARE).
The ARE is the major cis-determinant and up to 8% of
genes in the mammalian genome contain putative ARE
sequences in their 30-UTR (2). Based on sequence and
functional criteria, AREs are divided into three main groups.
Class I AREs contain multiple scattered AUUUA pentamer
motifs in a U rich region, class II AREs contains the
AUUUAUUUA motif which is composed of multiple
overlapping AUUUA pentamers, while class III AREs
which do not contain the AUUUA motif nevertheless are
uridine-rich and serve to promote decay. Most transcripts
encoding cytokines, growth factors and proto-oncogenes con-
tain AREs, examples of clinical significance being the c-fos, c-
myc and c-jun oncogenes, the cytokines IL-2, IL-3, IL-4, IL-6
and Granulocyte–macrophage colony-stimulating factor
(GM–CSF), the VEGF growth factor and the inflammatory
cytokine TNFa.
While such transcripts are present at low steady-state levels
in the cytoplasm due to their inherent lability, transient stabi-
lization under appropriate conditions leads to their rapid accu-
mulation and expression (3). Conventional methods of
detecting transcript stabilization are based first on blocking
transcription with a transcriptional inhibitor such as actinomy-
cin D, and harvesting the RNA at appropriate intervals. The
RNA is resolved by gel electrophoresis, transferred to mem-
branes and probed for the transcript of interest via northern
hybridizations. Alternatively, the levels of a particular tran-
script can also be detected via quantitative PCR. Stability is
then assessed by the decay or persistence of the transcript over
the time-course following actinomycin D addition. Such meth-
ods are labor intensive and time consuming making them ill-
suited for the rapid screening of large numbers of compounds
for their ability to influence mRNA turnover rates.
We describe here the application of a green fluorescent
protein (GFP)-based cellular assay where the GFP coding
transcript is rendered unstable by fusion to the IL-3 30-UTR
which contains a canonical class II ARE that is responsible for
destabilizing the native IL-3 transcript. Changes in transcript
stability are mirrored by altered GFP levels which are directly
measured by FACS analysis. Using this reporter system we
have identified okadaic acid as a potent stabilizer of the IL-3
ARE-containing mRNA. In addition, drugs with proven clin-
ical relevance score strongly and specifically in this assay. The
research potential of this system is also demonstrated by the
identification of upstream signaling pathways involved in
stabilization.
MATERIALS AND METHODS
Reagents
Chemicals were purchased from the following suppliers:
ionomycin, cyclosporin A, wortmannin, SB202190, FK506
and actinomycin D (Calbiochem); okadaic acid, rapamycin,
butyric acid, MG132 (Sigma); and SP600125, PD169316,
PD98059, U0126, Akt inhibitor (Alexis). Antibodies against
phospho-p38, p38, phospho-JNK, JNK were obtained from
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Cell Signaling Technologies. Goat anti-mouse and goat anti-
rabbit secondary antibodies were from Promega.
Cell culture
PB-3c-15 is a pre-malignant subclone of murine PB-3c mast
cells that is known to rapidly degrade endogenous IL-3
mRNA. PB-3c-15 cells that have been transformed with the
v-H-ras oncogene were inoculated and oncogenically trans-
formed in syngeneic mice and the V2D1 cell line was derived
from the resulting tumors (4). A V2D1 subclone, VG59, was
used in this study. All cells were maintained in Iscove’s med-
ium supplemented with 10% FCS, 100 U/ml penicillin,
100 mg/ml streptomycin, 50 mM 2-mercaptoethanol and 1%
conditioned medium from X63-mIL3 cells as a source of
exogenous IL-3. Stable transfectants were obtained by
electroporation with a GenePulser (BioRad) and selection
with hygromycin (1 mg/ml).
Plasmid constructs
The GFP–IL3wt reporter construct has been previously
described (5). Briefly, it consists of the mouse genomic 1.9 kb
HindIII–ApaI fragment containing the IL-3 promoter inserted
upstream of the EGFP promoter in pEGFP-N1 (Clontech).
The entire IL-3 promoter–GFP construct was cleaved out as
a HindIII–XbaI fragment and inserted into the IL3MXh-wt
vector. This step fused the GFP coding sequence upstream
of a portion of the terminal exon of IL-3 containing the entire
30-UTR including the poly(A) signal (Figure 1A). The GFP–
IL3DAU construct is similar except for the deletion of a 216 bp
NcoI–StyI fragment from the 30-UTR thereby removing the
entire ARE.
Flow cytometry
Around 105 cells were grown in 12-well dishes and stimulated
with the respective compounds for 4 h. After harvesting by
centrifugation, the cells were resuspended in a small volume
(200–400 ml) of phosphate-buffered saline (PBS) containing
propidium iodide (5 mg/ml) and kept on ice in the dark for
30 min. A total of 104 cells were analyzed using a FACScan
(Becton Dickinson) and the data processed with the CellQuest
program. GFP fluorescence was excited at 488 nm and emis-
sion was measured with a 510 nm filter. Propidium iodide
staining was detected with a 580 nm filter which allowed
exclusion of dead cells and cellular debris during data analysis.
Actinomycin chase mRNA decay assay
Control and treated cells were transcriptionally blocked with
actinomycin D (5 mg/ml) and cytoplasmic RNA was extracted
at the following time points: 0, 30, 60, 90 and 120 min. Twenty
micrograms of cytoplasmic RNA was resolved on a 1.1%
agarose–formaldehyde gel and blotted onto HyBondN+
nylon membranes (Amersham) overnight by capillary transfer
with 20· SSC. Membranes were probed for GFP-IL3 mRNA
using an SP6 radiolabeled RNA probe from the XbaI–EcoRI
fragment of murine IL-3 cDNA containing the IL-3 30-UTR.
For loading controls, cells were stripped and re-probed against
G3PDH, a stable, constitutively expressed transcript. Quanti-
fication of hybridizing signals was performed on a Phosphor-
Imager (Molecular Dynamics) using ImageQuant software.
The reporter GFP–IL3 mRNA signal was normalized to the
respective G3PDH reference signal after subtraction of the
filter background.
Western blotting
Cells were grown in 12-well plates with about 105 cells per
well. After pelleting, the cells were extracted with lysis buffers
containing Phosphatase Inhibitor Cocktail 1 and 2 (Sigma) and
protease inhibitors (Complete, Roche). Forty micrograms of
cell lysate protein was resolved on 12% SDS–PAGE gels and
electrophoretically transferred onto Immobilon membranes
(Millipore). Membranes were blocked in 5% skimmed milk
in TBS–0.1% Tween-20 (TBS-T) and shaken at 4C overnight
with the respective antibody. The membrane was washed four
times for 10 min in TBS-T and incubated with the secondary
alkaline phosphatase conjugated antibody for 1 h at room
temperature. The membrane was washed as before and the
signal developed with CDP-Star (Roche) for autoradiography.
RESULTS
Construction of GFP–IL3 reporter cell lines
PB-3c-15 cells were transfected with the GFP–IL3 plasmid
and selected with hygromycin to obtain a pool of stable trans-
fectants. The GFP–IL3 construct consists of the GFP coding
sequence upstream of the entire IL-3 30-UTR. The 59 nt long
ARE region has been previously shown to confer instability on
the IL-3 and heterologous transcripts (6). As shown schema-
tically in Figure 1A, the inherent instability of the reporter
transcript results in correspondingly low steady-state mRNA
levels of the transcript. This is mirrored by weak GFP fluor-
escence in cells expressing the reporter. However, upon sta-
bilization, levels of the transcript rise rapidly which results in a
rightward shift of the GFP peak as measured by FACS ana-
lysis. The reverse situation holds true in the case of further
destabilization of a transcript. GFP fluorescence of the trans-
fected cells was assessed by eye to select for GFP expressing
cells and was confirmed by FACS (data not shown). Individual
clones were obtained by dilution cloning for further testing.
To confirm that the GFP–IL3 transcript was indeed subject
to ARE-dependent destabilization we treated the subclones
with ionomycin, a calcium ionophore that is known to be a
potent stabilizer of IL-3 mRNA in these cells (7,8). FACS
profiles identified subclones with a low GFP baseline that
responded upon ionomycin treatment with significant
increases in GFP fluorescence. Of these subclones, one was
selected for further study and designated 15-GFP–IL3. A simi-
lar procedure was followed to obtain the control cell line
15-GFP-DAU lacking the ARE.
Screening of mRNA stabilizing compounds
Signaling pathways have been shown to regulate mRNA sta-
bility (9–12). Therefore we tested the effects of various kinase
and phosphatase inhibitors to promote or inhibit stabilization,
as well as previously described stabilizing agents. Compounds
screened were U0126 (MEK1/2 inhibitor), PD98059 (MEK1
inhibitor), SB202190 (p38MAPK inhibitor), PD169316
(p38MAPK inhibitor), wortmannin (PI3K inhibitor), rapamy-
cin (mTOR inhibitor), ionomycin (calcium ionophore), butyric
acid (HDAC inhibitor, pleiotropic effects), okadaic acid
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(PP2A inhibitor), Akt inhibitor, MG132 (proteasome
inhibitor), SP600125 (JNK inhibitor), cyclosporin A and
FK506. Cells were treated for 4 h and harvested for FACS
analysis. This was done in order to exclude non-specific
effects and to shorten the time for analysis as mRNA stabiliza-
tion is in any case a rapid process. Of all the compounds tested,
only okadaic acid (an inhibitor of the cellular phosphatase
PP2A) and MG132 (a proteasome inhibitor) gave a
significant shift in GFP fluorescence (Figure 1B) that was
comparable in magnitude to that induced by the known
stabilizer ionomycin.
The effects of both compounds were further investigated in
the control cell line 15-GFP-DAU. This contains a similar
GFP–IL3 reporter construct except for the deletion of the
entire ARE thereby resulting in the production of a
stable transcript. Any increase of GFP fluorescence in this
cell line would hence be due to a non-ARE-dependent
mechanism, most probably transcriptional upregulation or
even a translational effect. As seen in Figure 2A, neither
okadaic acid nor MG132 cause a major shift in the GFP
peak of 15-GFP-DAU.
To definitely confirm the RNA stabilizing properties
of these compounds, we performed an actinomycin D chase
mRNA decay assay. This confirmed okadaic acid as a
genuine stabilizing agent (Figure 2B). However, MG132
was shown to be unable to stabilize the reporter transcript
in this assay despite inducing a shift in GFP fluorescence
(Figure 1B).
Figure 1. (A) The 59 nt long ARE region of the mouse IL-3 30-UTR with AUUUA pentamers shown in boxes. A schematic representation of the GFP–IL3 reporter
construct and the expected FACS profiles under conditions of mRNA stabilization and destabilization. (B) A representative FACS profile of 15-GFP–IL3 cells after
treatment with ionomycin (1 mM), okadaic acid (400 nM) and MG132 (500 nM) for 4 h showing a substantial increase in GFP fluorescence.
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Regulation of okadaic acid- and ionomycin-induced
mRNA stabilization
Previous work from our laboratory has shown that ionomycin-
induced IL-3 mRNA stabilization in PB-3c cells operates via
activation of calcineurin (PP2B), a calcium-dependent phos-
phatase, as it could be antagonized by the calcineurin inhibi-
tors cyclosporin A and FK506 (13,14). Among the
downstreamsignalingpathways triggeredbycalcineurinactiva-
tion, the JNK pathway was shown to be required but not
sufficient for stabilization (10). We therefore sought to confirm
these earlier findings with our reporter system and, in addition,
to identify kinase/phosphatase inhibitors that were able to
antagonize pharmacologically induced stabilization. As
expected, ionomycin-induced stabilization was clearly antag-
onized in cells pre-incubated with cyclosporin A and
SP600125 [a JNK kinase inhibitor, (15)] (Figure 3A and C).
In contrast both cyclosporin A and SP600125 were unable to
inhibit okadaic acid-induced stabilization (Figure 3B and D)
indicating that it acts either by a distinct mechanism or down-
stream of calcineurin. Interestingly, a p38 MAPK inhibitor,
PD169316, could block stabilization in both cases (Figure 3E
and F) pointing to a central role of the p38 pathway in IL-3
mRNA stabilization in mast cells. To confirm the activation of
both pathways, western blotting on control and treated PB-3c-
15 cell lysates was performed with antibodies directed against
Figure 2. (A) A representative FACS profile of the control non-ARE cell line, 15-GFP-DAU, showing no significant increase in GFP fluorescence after similar
treatments with ionomycin, okadaic acid and MG132 as for the reporter cell line 15-GFP–IL3. (B) Actinomycin D chase mRNA decay assay of 15-GFP–IL3 cells over
a 2 h time course. The blots were probed for the GFP–IL3 30-UTR reporter to determine the rate of decay, then stripped and re-probed for the stable G3PD transcript for
loading controls and to normalize the GFP–IL3 hybridization signals for quantification. Quantified results (–SE) for four independent experiments are shown on the
graph. As shown, ionomycin and okadaic acid stabilize the reporter mRNA while MG132 is ineffective.
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the active, phosphorylated forms of the p38 and JNK kinases
(Figure 4). Both pathways were shown to be activated by
ionomycin in line with our previous data; interestingly, the
JNK pathway is even more strongly activated by okadaic acid
but is nevertheless inessential for okadaic acid-induced
stabilization (Figure 3).
Destabilization of GFP–IL3 mRNA
V2D1 is an autocrine tumor line derived from PB-3c-15 cells
expressing the v-H-ras oncogene after inoculation into syngeneic
mice. The key feature of V2D1 is the loss of IL-3 dependence
which is achieved by the establishment of an autocrine loop for
IL-3 production through constitutive stabilization of the IL-3
mRNA (16,17). A V2D1 subclone stably expressing the
GFP–IL3 reporter was created and designated VG59. Our
previous work has shown that stable IL-3 transcripts in these
cells can be destabilized with cyclophilins suchas cyclosporinA
and FK506 (14). To test if the reporter system is also capable of
detecting mRNA destabilization, we treated VG59 cells with
FK506 for 72 h followed by FACS analysis. The longer time
required for treatment is due to the stability of pre-existing GFP
Figure 3. Antagonization of ionomycin-induced mRNA stabilization by cyclosporin A (0.5 mg/ml), PD169316 (10 mM) and SP600125 (10 mM). In contrast, okadaic
acid-induced stabilization was uninhibited by cyclosporin A and SP600125 but was also sensitive to PD169316.
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protein which needs to be cleared before it can accurately reflect
the steady-state levels of the encoding transcript. In Figure 5 a
distinct back shift of the GFP peak is visible after FK506 treat-
ment in VG59 cells in line with expectations that this method
can, in principle, be used to detect mRNA destabilization.
DISCUSSION
While the number of genes known to be post-transcriptionally
regulated has grown, this has not been accompanied by similar
progress in identifying compounds capable of modulating
mRNA stability. This is largely due to the time-consuming
and labor-intensive nature of standard mRNA decay assays
which do not permit rapid, large-scale screening of potential
stabilizing agents.
The reporter system presented here has the advantage of
providing quick (<5 h), reliable and quantitative results. As
only a small number of cells are required for FACS analysis
(104 cells), the size of the experiment can be scaled up or down
as required in an appropriate multi-well format to screen any
number of compounds with the relevant time and dilution
series. In addition, the small number of steps required suggests
that it will lend itself easily to automation. Using this system
we have identified okadaic acid and MG132 as potential sta-
bilizers of IL-3 mRNA (Figure 1B). Okadaic acid, but not
MG132, was confirmed as a genuine mRNA stabilizer via
standard methods (Figure 2B). MG132 has previously been
shown to stabilize the class II ARE present in the GM–CSF
mRNA in HeLa cells (18). The apparent GFP shift observed
with MG132 treatment is most likely due to reduced turnover
of GFP at the protein level due to its anti-proteosomal proper-
ties (19) rather than actual stabilization of the reporter tran-
script. This illustrates that this reporter system would function
best as a large-scale primary screen for potential stabilizing
compounds that would then require further confirmation.
We also obtained evidence for the involvement of several
signaling pathways in inducing stabilization (Figure 3). The
central role of the p38 MAPK pathway in ionomycin- and
okadaic acid-induced stabilization is consistent with other
reports (20,21) indicating common regulatory mechanisms
controlling stability. While this demonstrates the research
potential of the technique, it may also have practical applica-
tion as the regulation of mRNA stabilization is of potential
clinical significance as in, e.g. modulating the levels of
cytokines.
Although we have constructed the ARE and the non-ARE
reporters in separate cell lines, it is technically feasible to
insert both constructs in the same cell line with the proviso
that they are linked to reporter molecules with different emis-
sion wavelengths (e.g. a GFP–ARE reporter versus an RFP–
DARE reporter). As a large-scale screen will presumably
uncover effects unrelated to ARE-dependent decay but cap-
able of affecting GFP protein levels (i.e. stimulation of tran-
scription/translation, reduced turnover of GFP protein, etc.), it
is critical that such a double-reporter cell line is used for actual
screening. This will, in addition, provide simultaneous
data collection while serving as an internal control to
distinguish between ARE-dependent and non-ARE-dependent
stabilization.
Figure 5. FACS profile of VG59 cells treated with FK506 (1 mg/ml) for 72 h.
Figure 4. Western blots of 15-GFP–IL3 lysates treated with ionomycin,
okadaic acid and MG132 for 30 min. Activation of the p38 MAPK pathway
was determined with an antibody directed against the phosphorylated, active
form of p38. JNK pathway activation was determined with a similar phospho-
specific antibody that detects two phosphorylated isoforms of JNK (46 and
54 kDa), and a non-specific (NS) band. Blots were stripped and re-probed with
antibodies against the unphosphorylated forms of the proteins as loading
controls.
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A further technical refinement would be the use of a more
labile reporter molecule to facilitate investigations into mRNA
destabilization. Our results with a destabilizing agent, FK506,
while establishing a proof in principle of the applicability of
this method in detecting mRNA destabilization (Figure 5),
may not represent an ideal situation as the long treatment
times required (72 h) can conceivably give rise to non-specific
secondary effects. The availability of more labile forms of
GFP (22) provides a ready solution that should feature in
future developments of this method.
Regulated mRNA decay is a multi-step process that can be
divided into: regulation of AUBP activity, AUBP binding to
the ARE, deadenylation of the poly(A) tail by PARN and 30–50
degradation of the deadenylated transcript by the cytoplasmic
exosome (Figure 6). The AUBP can promote decay either by
accelerating the degradation of the poly(A) tail or by direct
recruitment of the exosome. Due to the sequential nature of
events involved in effecting decay, it is possible in theory to
screen for inhibitors at several steps of the process. Our results
with phosphatase/kinase inhibitors indicate that ionomycin-
and okadaic acid-induced stabilization is effected at the
level of AUBP regulation. It is possible with a larger screen,
to perhaps identify inhibitors of PARN or the exosome.
While we have limited our studies to the IL-3 ARE, which is
a class II ARE, this approach can obviously be applied to any
ARE or cis-determinant of interest and similar flexibility
applies to the choice of cell line to be studied. Indeed we
have constructed similar reporter systems for the CDE of
the TNFa 30-UTR (23), and in various cell lines, namely
RAW264.7 and HT1080 (24).
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